Company Filing History:
Years Active: 2020-2024
Title: Innovations in Pharmaceutical Compositions: The Contributions of Weng Li Yoon
Introduction: Weng Li Yoon is an accomplished inventor based in Hong Kong, CN, recognized for his significant contributions to the pharmaceutical industry. With a total of two patents under his name, Yoon has focused on enhancing drug formulations to improve absorption and stability, particularly for taxanes, which are critical in cancer treatment.
Latest Patents: Weng Li Yoon's latest patent revolves around oral taxane compositions and methods. This innovative pharmaceutical composition involves a mixture of taxanes such as paclitaxel, docetaxel, cabazitaxel, larotaxel, ortataxel, and tesetaxel, combined with first and second surfactants. His formulation significantly increases the absorption of taxanes beyond the individual absorption levels achieved with either surfactant alone. The optimal ratio of first to second surfactants is crucial and ranges from 60:40 to 85:15 by weight, ensuring the total surfactant weight does not exceed 98% of the overall composition. Suitable first surfactants include polysorbate 80, polysorbate 20, and caprylocaproyl polyoxylglycerides, while polysorbate 80 and polyethyoxylated castor oil serve as effective second surfactants. To further enhance stability, Yoon’s formulations may also incorporate stabilizers like citric acid and ascorbic acid.
Career Highlights: Throughout his career, Weng Li Yoon has made significant strides in pharmaceutical research and development. He has worked with notable companies such as Athenex HK Innovative Limited and Health Hope Pharma Ltd. His expertise in drug formulation has positioned him as a valuable contributor in the field of pharmaceuticals.
Collaborations: Weng Li Yoon has collaborated with several professionals in the industry, including Denise S. B. Chan and Ming Tsung Lee. These collaborations reflect his commitment to advancing pharmaceutical technologies and improving drug delivery methods.
Conclusion: Weng Li Yoon's innovations in oral taxane compositions highlight his pivotal role in transforming pharmaceutical research. His work not only enhances the effectiveness of treatment regimens for cancer patients but also underscores the importance of collaboration in the field of drug development. With his two patents, Yoon continues to be a driving force in pharmaceutical innovation.